How were Loxo Oncology's earnings last quarter?
Loxo Oncology Inc (NASDAQ:LOXO) announced its quarterly earnings results on Thursday, August, 9th. The biopharmaceutical company reported ($0.39) e...
Who are Loxo Oncology's key executives?
Loxo Oncology's management team includes the following people: Dr. Joshua H. Bilenker , Founder, Pres, CEO & Director (Age 47) Ms. Jennifer Burs...
Who are some of Loxo Oncology's key competitors?
Some companies that are related to Loxo Oncology include Astellas Pharma (ALPMY) , Royalty Pharma (RPRX) , MERCK Kommanditgesellschaft auf Aktie...
What other stocks do shareholders of Loxo Oncology own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Loxo Oncology investors own include Alibaba Group (BABA) ,...
What is Loxo Oncology's stock symbol?
Loxo Oncology trades on the NASDAQ under the ticker symbol "LOXO."
What is Loxo Oncology's stock price today?
One share of LOXO stock can currently be purchased for approximately $234.66.
How much money does Loxo Oncology make?
Loxo Oncology (NASDAQ:LOXO) has a market capitalization of $7.18 billion and generates $21.30 million in revenue each year. The biopharmaceutical c...
What is Loxo Oncology's official website?
The official website for Loxo Oncology is www.loxooncology.com .
How can I contact Loxo Oncology?
Loxo Oncology's mailing address is 281 TRESSER BOULEVARD 9TH FLOOR, STAMFORD CT, 06901 . The biopharmaceutical company can be reached via phone at...
How were Loxo Oncology's earnings last quarter?
Loxo Oncology Inc (NASDAQ:LOXO) released its quarterly earnings results on Thursday, August, 9th. The biopharmaceutical company reported ($0.39) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.54) by $0.15.
Who are some of Loxo Oncology's key competitors?
Some companies that are related to Loxo Oncology include MERCK Kommanditgesellschaft auf Aktien (MKGAF), Takeda Pharmaceutical (TKPYY), Shiseido (SSDOY), Royalty Pharma (RPRX), Genmab A/S (GNMSF), BeiGene (BGNE), Horizon Therapeutics Public (HZNP), Genmab A/S (GMAB), UCB (UCBJF), Alnylam Pharmaceuticals (ALNY), Viatris (VTRS), Catalent (CTLT), BioMarin Pharmaceutical (BMRN), Ono Pharmaceutical (OPHLF) and Elanco Animal Health (ELAN). View all of LOXO's competitors..
What other stocks do shareholders of Loxo Oncology own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Loxo Oncology investors own include Alibaba Group (BABA), GW Pharmaceuticals (GWPH), NVIDIA (NVDA), (CGC), Netflix (NFLX), (CELG), AbbVie (ABBV), Micron Technology (MU), Advanced Micro Devices (AMD) and Johnson & Johnson (JNJ).
What is Loxo Oncology's stock price today?
One share of LOXO stock can currently be purchased for approximately $234.66.
How much money does Loxo Oncology make?
Loxo Oncology has a market capitalization of $7.18 billion and generates $21.30 million in revenue each year. The biopharmaceutical company earns $-148.87 million in net income (profit) each year or ($5.31) on an earnings per share basis.
Where are Loxo Oncology's headquarters?
Loxo Oncology is headquartered at 281 TRESSER BOULEVARD 9TH FLOOR, STAMFORD CT, 06901.
How can I contact Loxo Oncology?
Loxo Oncology's mailing address is 281 TRESSER BOULEVARD 9TH FLOOR, STAMFORD CT, 06901. The biopharmaceutical company can be reached via phone at 203-653-3880 or via email at prahmer@troutgroup.com.